Annual report pursuant to Section 13 and 15(d)

Dispositions - Additional Information (Details)

v3.6.0.2
Dispositions - Additional Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2015
Nov. 05, 2015
Nov. 04, 2015
Dec. 31, 2015
Dec. 31, 2015
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]          
Gain on sale of business         $ 3,505,000
Biodefense Business [Member]          
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]          
Sales of business, number of common stock shares eligible to receive     23,008    
Royalties receivable percentage on net sales     15.00%    
Biodefense Business [Member] | Maximum [Member]          
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]          
Cash payments from Nanotherapeutics     $ 4,500,000    
Manufacturing Facility in Berkeley, California [Member] | Other Income (Expense), Net [Member]          
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]          
Gain on sale of business       $ 3,500,000  
Manufacturing Facility in Berkeley, California [Member] | Agenus Purchase Agreement [Member]          
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]          
Cash received from sale of business $ 4,700,000        
Sale of business, value of common stock shares received 500,000     500,000 500,000
Liabilities assumed $ 300,000        
Sales of business, number of common stock shares received 109,211        
Contingent consideration value of common stock to be received         500,000
Consideration received for employees who would not have otherwise been retained         200,000
Carrying value of business sold $ 2,200,000     $ 2,200,000 2,200,000
Manufacturing Facility in Berkeley, California [Member] | Agenus Purchase Agreement [Member] | Other Income (Expense), Net [Member]          
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]          
Gain on sale of business         $ 3,500,000
Manufacturing Facility in Berkeley, California [Member] | Maximum [Member] | Agenus Purchase Agreement [Member]          
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]          
Cash received from sale of business   $ 5,000,000      
Sale of business, value of common stock shares received   $ 1,000,000